Selected research
Market Structure
Global Fully MagLev Ventricular Assist Device (VAD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Fully MagLev Ventricular Assist Device (VAD) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Fully MagLev Ventricular Assist Device (VAD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Fully MagLev Ventricular Assist Device (VAD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Fully MagLev Ventricular Assist Device (VAD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Fully MagLev Ventricular Assist Device (VAD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Fully MagLev Ventricular Assist Device (VAD) include BiVACOR, Shenzhen Core Medical Technology, Suzhou Tongxin Medical Devices and Abbott, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Fully MagLev Ventricular Assist Device (VAD) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Fully MagLev Ventricular Assist Device (VAD) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Fully MagLev Ventricular Assist Device (VAD) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fully MagLev Ventricular Assist Device (VAD) market size, projected growth trends, production technologies, key applications, and end-use industries.
Fully MagLev Ventricular Assist Device (VAD) Segment by Company
BiVACOR
Shenzhen Core Medical Technology
Suzhou Tongxin Medical Devices
Abbott
Fully MagLev Ventricular Assist Device (VAD) Segment by Type
Left Ventricular Assist Device (LVAD)
Biventricular Assist Device (BiVAD)
Fully MagLev Ventricular Assist Device (VAD) Segment by Application
Bridge-to-transplant (BTT)
Destination Therapy (DT)
Others
Fully MagLev Ventricular Assist Device (VAD) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fully MagLev Ventricular Assist Device (VAD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fully MagLev Ventricular Assist Device (VAD) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fully MagLev Ventricular Assist Device (VAD).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Fully MagLev Ventricular Assist Device (VAD) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fully MagLev Ventricular Assist Device (VAD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fully MagLev Ventricular Assist Device (VAD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Fully MagLev Ventricular Assist Device (VAD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Left Ventricular Assist Device (LVAD)
- Biventricular Assist Device (BiVAD)
Applications
- Bridge-to-transplant (BTT)
- Destination Therapy (DT)
- Others
Companies covered
- BiVACOR
- Shenzhen Core Medical Technology
- Suzhou Tongxin Medical Devices
- Abbott
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Fully MagLev Ventricular Assist Device (VAD) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Fully MagLev Ventricular Assist Device (VAD) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Fully MagLev Ventricular Assist Device (VAD) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Fully MagLev Ventricular Assist Device (VAD) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Fully MagLev Ventricular Assist Device (VAD) Market Dynamics
- 2.1 Fully MagLev Ventricular Assist Device (VAD) Industry Trends
- 2.2 Fully MagLev Ventricular Assist Device (VAD) Industry Drivers
- 2.3 Fully MagLev Ventricular Assist Device (VAD) Industry Opportunities and Challenges
- 2.4 Fully MagLev Ventricular Assist Device (VAD) Industry Restraints
3 Fully MagLev Ventricular Assist Device (VAD) Market by Manufacturers
- 3.1 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Manufacturers (2021-2026)
- 3.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Manufacturers (2021-2026)
- 3.3 Global Fully MagLev Ventricular Assist Device (VAD) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Fully MagLev Ventricular Assist Device (VAD) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Fully MagLev Ventricular Assist Device (VAD) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Fully MagLev Ventricular Assist Device (VAD) Manufacturers, Product Type & Application
- 3.7 Global Fully MagLev Ventricular Assist Device (VAD) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Fully MagLev Ventricular Assist Device (VAD) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Fully MagLev Ventricular Assist Device (VAD) Players Market Share by Revenue in 2025
- 3.8.3 2025 Fully MagLev Ventricular Assist Device (VAD) Tier 1, Tier 2, and Tier 3
4 Fully MagLev Ventricular Assist Device (VAD) Market by Type
- 4.1 Fully MagLev Ventricular Assist Device (VAD) Type Introduction
- 4.1.1 Left Ventricular Assist Device (LVAD)
- 4.1.2 Biventricular Assist Device (BiVAD)
- 4.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Type
- 4.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Type (2021-2032)
- 4.2.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales Market Share by Type (2021-2032)
- 4.3 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Type
- 4.3.1 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Type (2021-2032)
- 4.3.3 Global Fully MagLev Ventricular Assist Device (VAD) Revenue Market Share by Type (2021-2032)
5 Fully MagLev Ventricular Assist Device (VAD) Market by Application
- 5.1 Fully MagLev Ventricular Assist Device (VAD) Application Introduction
- 5.1.1 Bridge-to-transplant (BTT)
- 5.1.2 Destination Therapy (DT)
- 5.1.3 Others
- 5.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Application
- 5.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Application (2021-2032)
- 5.2.3 Global Fully MagLev Ventricular Assist Device (VAD) Sales Market Share by Application (2021-2032)
- 5.3 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Application
- 5.3.1 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Application (2021-2032)
- 5.3.3 Global Fully MagLev Ventricular Assist Device (VAD) Revenue Market Share by Application (2021-2032)
6 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region
- 6.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region (2021-2032)
- 6.2.1 Global Fully MagLev Ventricular Assist Device (VAD) Sales by Region (2021-2026)
- 6.2.2 Global Fully MagLev Ventricular Assist Device (VAD) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Fully MagLev Ventricular Assist Device (VAD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Fully MagLev Ventricular Assist Device (VAD) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Fully MagLev Ventricular Assist Device (VAD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Fully MagLev Ventricular Assist Device (VAD) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Fully MagLev Ventricular Assist Device (VAD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Fully MagLev Ventricular Assist Device (VAD) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Region
- 7.1 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Region
- 7.1.1 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Region (2021-2026)
- 7.1.3 Global Fully MagLev Ventricular Assist Device (VAD) Revenue by Region (2027-2032)
- 7.1.4 Global Fully MagLev Ventricular Assist Device (VAD) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Fully MagLev Ventricular Assist Device (VAD) Revenue (2021-2032)
- 7.2.2 North America Fully MagLev Ventricular Assist Device (VAD) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Fully MagLev Ventricular Assist Device (VAD) Revenue (2021-2032)
- 7.3.2 Europe Fully MagLev Ventricular Assist Device (VAD) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Fully MagLev Ventricular Assist Device (VAD) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Fully MagLev Ventricular Assist Device (VAD) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 BiVACOR
- 8.1.1 BiVACOR Company Information
- 8.1.2 BiVACOR Business Overview
- 8.1.3 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 BiVACOR Fully MagLev Ventricular Assist Device (VAD) Product Portfolio
- 8.1.5 BiVACOR Recent Developments
- 8.2 Shenzhen Core Medical Technology
- 8.2.1 Shenzhen Core Medical Technology Company Information
- 8.2.2 Shenzhen Core Medical Technology Business Overview
- 8.2.3 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Shenzhen Core Medical Technology Fully MagLev Ventricular Assist Device (VAD) Product Portfolio
- 8.2.5 Shenzhen Core Medical Technology Recent Developments
- 8.3 Suzhou Tongxin Medical Devices
- 8.3.1 Suzhou Tongxin Medical Devices Company Information
- 8.3.2 Suzhou Tongxin Medical Devices Business Overview
- 8.3.3 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Suzhou Tongxin Medical Devices Fully MagLev Ventricular Assist Device (VAD) Product Portfolio
- 8.3.5 Suzhou Tongxin Medical Devices Recent Developments
- 8.4 Abbott
- 8.4.1 Abbott Company Information
- 8.4.2 Abbott Business Overview
- 8.4.3 Abbott Fully MagLev Ventricular Assist Device (VAD) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Abbott Fully MagLev Ventricular Assist Device (VAD) Product Portfolio
- 8.4.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Fully MagLev Ventricular Assist Device (VAD) Value Chain Analysis
- 9.1.1 Fully MagLev Ventricular Assist Device (VAD) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Fully MagLev Ventricular Assist Device (VAD) Production Mode & Process
- 9.2 Fully MagLev Ventricular Assist Device (VAD) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Fully MagLev Ventricular Assist Device (VAD) Distributors
- 9.2.3 Fully MagLev Ventricular Assist Device (VAD) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst